Trial record 12 of 48 for:    child [AGE-GROUP] "drug abuse" | Open Studies

Impact of Online Patient Feedback (OQ) to Therapist

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2013 by Oslo University Hospital
Sponsor:
Collaborator:
University of Oslo
Information provided by (Responsible Party):
Oslo University Hospital
ClinicalTrials.gov Identifier:
NCT01891045
First received: July 6, 2012
Last updated: June 27, 2013
Last verified: June 2013
  Purpose

Dropout represents one of the largest problems in substance abuse treatment. International and Nordic research show that only 20 - 40 % of substance abusers complete treatment as intended. At the same time, one of the most consistent factors of favourable post-treatment outcome is treatment completion. In spite of the serious and continuous challenge dropout represents the phenomena is not well understood and there is a need to explore more of the factors that influence dropout and how it can be counteracted. As also stated: "…effective methods for reducing the problem of dropouts from treatment is one more area in need of further research" (NOU 2003:4, s 77).

For the general field of mental health one of the most important innovations involves providing therapists with patient feedback about their progress. The most well-established and widely researched feedback system is the Outcome Questionnaire (OQ-45.2). The system has been shown to improve treatment outcomes, including reduced treatment dropout and length of treatment, but the system is yet to be utilized with a substance abusing patient group. The aim of the present study is to examine the usefulness of OQ-45.2 with substance abusing patients.


Condition Intervention Phase
Drug Addiction
Drug Abuse
Behavioral: OQ-45.2 no feedback
Behavioral: OQ-45.2
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Addiction Treatment Dropout Prevention - Impact of Online Patient Feedback (OQ-45.2) to Therapist

Further study details as provided by Oslo University Hospital:

Primary Outcome Measures:
  • Drop-out [ Time Frame: Four years ] [ Designated as safety issue: No ]
    The main goal of the present study is to examine the usefulness of OQ-45.2 with regard to reducing dropout from substance abuse treatment.


Estimated Enrollment: 160
Study Start Date: July 2011
Estimated Study Completion Date: July 2015
Estimated Primary Completion Date: November 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: Control
Patients merely monitored on background variables to function as a baseline of comparison
Active Comparator: Prediction
Patients randomized to this condition completes the OQ-45.2 weekly, but the reports are withheld from therapists and patients.
Behavioral: OQ-45.2 no feedback
Completion of the OQ-45.2 before each session, but no feedback to therapists or patients
Experimental: Intervention
Patients and therapists uses the feedback-system as intended, with real-time feedback to the therapist and full use of the suggested interventions
Behavioral: OQ-45.2
Completion of the OQ-45.2 with real-time feedback to the therapist and full use of the suggested interventions every week of the treatment program

Detailed Description:

Hypotheses and research questions

1. The OQ-45.2 feedback will be effective in identifying patients at risk of dropout of substance abuse treatment.

1a. The condition were feedback is withheld from the therapist, will correctly identify patients who will dropout.

Research Question: Is there variation in the accuracy of dropout prediction as a function of age, gender differences or type of substance abuse?

2. The OQ-45.2 feedback will be effective in reducing dropout in outpatient substance abuse treatment.

2a. The feedback condition will result in less dropout than the no-feedback condition.

Research Question: Is there a variation in the OQ-45.2 preventive dropout effect due to age, gender or type of substance abuse?

3. The OQ-45.2 feedback will shorten length of inpatient substance abuse treatment.

3a. The feedback condition will identify patients who are ready to terminate therapy.

Research Question: Is there variation in identification of patients ready to terminate as a function of age, gender differences or type of substance abuse?

  Eligibility

Ages Eligible for Study:   16 Years to 26 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Primary diagnosis of addiction, F10-19, using the International Classification of Diseases, admitted in 2011-2014 for treatment at the department of addiction treatment - youth, Oslo University Hospital

Exclusion Criteria:

  • Ongoing psychoses, severe language difficulties
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01891045

Contacts
Contact: Hanne Brorson, MA hanne.brorson@psykologi.uio.no
Contact: Espen Walderhaug, PHD espen.walderhaug@psykologi.uio.no

Locations
Norway
Oslo University Hospital - Department of addiction treatment youth Recruiting
Oslo, Norway, 0514
Contact: Hanne Brorson, MA       hanne.brorson@psykologi.uio.no   
Contact: Espen Walderhaug, PhD       espen.walderhaug@psykologi.uio.no   
Principal Investigator: Hanne Brorson         
Department of addiction treatment- youth Recruiting
Oslo, Norway, 0514
Contact: Espen Arnevik, PhD       esarne@ous-hf.no   
Contact: Espen Walderhaug, PhD       espen.walderhaug@psykologi.uio.no   
Principal Investigator: Hanne Brorson, PhD         
Sponsors and Collaborators
Oslo University Hospital
University of Oslo
  More Information

No publications provided

Responsible Party: Oslo University Hospital
ClinicalTrials.gov Identifier: NCT01891045     History of Changes
Other Study ID Numbers: OQ45-11-1
Study First Received: July 6, 2012
Last Updated: June 27, 2013
Health Authority: Norway: Regional Ethics Commitee
Norway: Data Protection Authority

Keywords provided by Oslo University Hospital:
Psychotherapy
Drug addiction
Drop-out
OQ-45.2
Clinical trial
Randomized Controlled Trail

Additional relevant MeSH terms:
Behavior, Addictive
Compulsive Behavior
Impulsive Behavior

ClinicalTrials.gov processed this record on September 22, 2014